Showing results (581-590 of 658) with videos related to

Sort By:
Pageof 66
Neuro-Oncology|May 15, 2016
Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patientsAmy K LeBlanc, Christina Mazcko, Diane E Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01Andrew B Lassman, Michael R Rossi, Jeffrey J Raizer, et al.
Neuro-Oncology Advances|October 27, 2022
Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825Michael E Scheurer, Renke Zhou, Mark R Gilbert, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 13, 2015
Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic ImpactPratheesh Sathyan, Pascal O Zinn, Anantha L Marisetty, et al.
Journal of Proteome Research|December 20, 2012
Chromosome 19 annotations with disease speciation: a first report from the Global Research ConsortiumCarol L Nilsson, Frode Berven, Frode Selheim, et al.
Neuro-Oncology Practice|September 20, 2022
The Montreal Cognitive Assessment (MoCA) in neuro-oncology: A pilot study of feasibility and utility in telehealth and in-person clinical assessmentsVarna Jammula, James L Rogers, Elizabeth Vera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2018
Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 AntagonismVarun V Prabhu, Neel S Madhukar, Coryandar Gilvary, et al.
Research Square|February 15, 2023
Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trialAmanda L King, Kayla N Roche, Heather E Leeper, et al.
Neuro-Oncology Advances|April 22, 2026
CERN 09-02: A phase 2 trial of carboplatin and bevacizumab for recurrent adult ependymomasShuodan Zhang, Byram H Ozer, Antonio Omuro, et al.
Neuro-Oncology|February 13, 2021
Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6qLorena V Baroni, Lakshmikirupa Sundaresan, Ayala Heled, et al.
Pageof 66